Hodgkin Lymphoma Trial Results
- Rituximab Retreatment after Disease Progression Is Comparable to Rituximab Maintenance Therapy in Patients with Low-Tumor Burden Follicular Lymphoma
(Posted: 10/02/2014) - In a randomized clinical trial, patients with low–tumor burden follicular lymphoma whose cancer responded to initial treatment with rituximab (Rituxan®) experienced similar disease control regardless of whether they subsequently received maintenance therapy with rituximab or were retreated with rituximab only when there was evidence of disease progression.
- Late Effects May Not Warrant Using Radiation to Treat Early-Stage Hodgkin Lymphoma
(Posted: 12/22/2011) - Patients with early-stage Hodgkin lymphoma who were treated with multidrug chemotherapy alone were more likely to be alive 12 years later than patients who received treatment that included radiation therapy, according to findings from a phase III clinical trial.
- Adding Radiation to Chemotherapy May Improve Outcomes in Early-Stage Hodgkin Lymphoma
(Posted: 05/12/2011) - Adding radiation therapy to chemotherapy may improve outcomes in patients with early-stage Hodgkin lymphoma, according to a paper published in the Cochrane Database of Systematic Reviews in February 2011, but the long-term effects of this regimen are not known.
- Trial Suggests New Treatment Option for Hodgkin Lymphoma
(Posted: 12/27/2010) - Intermediate results from a phase II clinical trial presented at the 2010 American Society of Hematology annual meeting indicate that an investigational agent called brentuximab vedotin may be an effective alternative for some patients with Hodgkin lymphoma who have few viable treatment options.
- Novel Drug Effectively Shrinks Tumors in Hodgkin Lymphoma
(Posted: 12/07/2010) - An investigational drug composed of a monoclonal antibody linked to a potent chemotherapy agent led to complete or substantial tumor shrinkage in nearly 40 percent of patients with Hodgkin lymphoma in a phase I clinical trial, researchers reported November 4, 2010, in the New England Journal of Medicine.